The Group

Our research program focuses on cancer biology, in particular the role of angiogenesis and lymphangiogenesis towards tumor metastasis, as well as on the molecular control of chronic inflammation.

A major focus of the group is the genetic disposition for disease and for the response to specific therapies, with the aim to develop new individualized therapies for human diseases.

JavaScript has been disabled in your browser